Halozyme Therapeutics
HALO
#1943
Rank
$6.99 B
Marketcap
$51.77
Share price
1.27%
Change (1 day)
49.58%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2022 (TTM): $1.53

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $1.53. In 2021 the company made an earnings per share (EPS) of $2.85 an increase over its 2020 EPS that were of $0.96.

EPS history for Halozyme Therapeutics from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$1.53-46.32%
2021$2.85196.88%
2020$0.96-292%
2019-$0.50-9.09%
2018-$0.55-237.5%
2017$0.40-149.38%
2016-$0.81211.54%
2015-$0.26-52.73%
2014-$0.55-24.66%
2013-$0.7348.98%
2012-$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.28 375.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.31 247.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.48 323.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.30 115.50%๐Ÿ‡ซ๐Ÿ‡ท France
-$4.71-407.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.38-124.84%๐Ÿ‡บ๐Ÿ‡ธ USA